Bulletin Updates
Epigral Ltd: Derivatives growth, revenue dip – 4 Sep 2023
Sep 04, 2023
In Q1FY24, Epigral Limited, previously known as Meghmani Finechem Limited, saw growth in its Derivatives & Specialty Chemical segment but faced reduced revenues due to lower product prices
The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »
Log in Start a free trial »